Oppenheimer & CO Inc Precigen, Inc. Transaction History

Oppenheimer & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $3,948 - $7,812	-2,800 Reduced 18.79%	12,100 $26,000
Q2 2022 Aug 08, 2022	SELL	$1.15 - $2.53 $6,784 - $14,926	-5,900 Reduced 28.37%	14,900 $20,000
Q4 2021 Feb 02, 2022	SELL	$3.53 - $5.5 $6,707 - $10,450	-1,900 Reduced 8.37%	20,800 $77,000
Q2 2021 Aug 03, 2021	BUY	$6.24 - $8.22 $141,648 - $186,594	22,700 New	22,700 $148,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.